Practice Tool
The American Academy of Pediatrics recently revised its guidelines for the management and prevention of hyperbilirubinemia in the newborn infant ≥35 weeks’ gestation. This practice tool overviews hyperbilirubinemia risk assessment, monitoring, and treatment.
Clinical Pathways
Hyperbilirubinemia
This inpatient Hyperbilirubinemia clinical pathway outlines the recommended evaluation and management to prevent risk of kernicterus.
Hyperbilirubinemia
The clinical pathway is to increase compliance to 2022 AAP Clinical practice Guidelines for Mx of Hyperbilirubinemia in neonates.
Helping Hands
Jaundice in Children
Jaundice is a common condition in newborns that occurs when a yellow pigment (bilirubin) cannot be removed from the body fast enough and levels in the blood become too high. The buildup of bilirubin causes the skin and the white part of the eyes to appear yellow. Most cases clear without treatment.